Aarvik Therapeutics

United States
Clintonville, Wisconsin, United States

Company profile

Aarvik Therapeutics company profile

Aarvik Therapeutics combines a unique, proprietary modular platform with multiple target mechanisms to develop novel molecules with an improved therapeutic index for oncology targets. Backed by the extensive scientific research, development, and investment expertise of its founders and Board members, Aarvik Therapeutics is applying its vision and passion to create transformational benefits for cancer patients.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2020-01-01

Headquarters

Headquarters
Clintonville, Wisconsin, United States
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
3
Total equity funding
$11.5M
Last funding
Seed / $2M / 2025-09-29
Last equity funding
Seed / $2M
Investors
1
Lead investors
1
Founders
2
Articles
11

Founders and investors

Founders

Jagath Reddy JunutulaSachdev Sidhu

Lead investors

Laurus Labs

Investors

Laurus Labs

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.